Inventor

Cheng Li

Inventor

Shanghai, CN

Overview

2→

Patents

2020

Patent span

Chemistry

Primary field (CPC C)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes13%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%

C07DHeterocyclic compounds13%

C12NMicroorganisms or enzymes13%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture13%

C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms13%

C12YEnzymes13%

Y02ATechnologies for adaptation to climate change13%

PatentTitleYear

10,738,051b-lactamase inhibitors2020 10,683,487None2020

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2020Patents assigned to NAT UNIV KAOHSIUNG (1)· patent assignee history

2020Patents assigned to QILU PHARMACEUTICAL CO LTD (1)· patent assignee history

2020Based in Shanghai, CN· patent location history

2020Based in Kaohsiung, TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
NAT UNIV KAOHSIUNG	1	2020
QILU PHARMACEUTICAL CO LTD	1	2020

Locations

Location	Patents	Span
Shanghai, CN	1	2020
Kaohsiung, TW	1	2020